Cargando…
Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
BACKGROUND: The oncogene CDC25B phosphatase plays an important role in cancer cell growth. We have recently reported that patients with esophageal squamous cell carcinoma (ESCC) have significantly higher serum levels of CDC25B autoantibodies (CDC25B-Abs) than both healthy individuals and patients wi...
Autores principales: | Dong, Jun, Zeng, Bo-hang, Xu, Li-hua, Wang, Jun-ye, Li, Man-Zhi, Zeng, Mu-sheng, Liu, Wan-li |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941748/ https://www.ncbi.nlm.nih.gov/pubmed/20813067 http://dx.doi.org/10.1186/1479-5876-8-81 |
Ejemplares similares
-
Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010) -
Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020) -
High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis
por: Huang, Zhi-Liang, et al.
Publicado: (2015) -
Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma
por: Zhang, Hang, et al.
Publicado: (2013) -
DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)